Literature DB >> 15914134

Male tolerance of ACIDFORM gel.

Jill L Schwartz1, Alfred Poindexter, Susan W Schmitz, Christine Mauck, Marianne M Callahan.   

Abstract

BACKGROUND: ACIDFORM gel is being studied as a vaginal contraceptive and microbicide. This study was conducted to make certain that males will not be subjected to an unacceptable risk of penile irritation as a result of exposure to the product in future studies.
METHODS: This was a randomized, double-masked, single-center Phase I study in circumcised and uncircumcised men to assess penile irritation, safety and acceptability of seven consecutive doses of ACIDFORM gel compared with K-Y Jelly Personal Lubricant. Each participant was instructed to apply 2 mL of the study product to his penis at bedtime, to wash it off 6-10 h later and to record any symptoms on a diary card. At the follow-up visit, a genital examination was performed and participants were asked about adverse events (AEs) and completed an acceptability questionnaire.
RESULTS: Of the 36 men enrolled, 2 out of 24 (8.3%) ACIDFORM gel users and 5 out of 12 (41.7%) K-Y Jelly users reported genital symptoms. Genital examination findings were observed in 2 out of 24 (8.3%) ACIDFORM gel users and in 1 out of 12 (8.3%) K-Y Jelly users. All product-related AEs were considered mild except for two in the K-Y Jelly group. Both products were acceptable.
CONCLUSION: ACIDFORM gel applied to the penis for seven consecutive days appears to be at least as safe and well-tolerated as the marketed lubricant K-Y Jelly among healthy low-risk men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914134     DOI: 10.1016/j.contraception.2004.11.008

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

Review 1.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

2.  A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).

Authors:  Ross D Cranston; Craig Hoesley; Alex Carballo-Diéguez; Craig W Hendrix; Marla Husnik; Lisa Levy; Wayne Hall; Lydia Soto-Torres; Annalene M Nel
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-26       Impact factor: 2.205

3.  A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial.

Authors:  Michael A Thomas; B Todd Chappell; Bassem Maximos; Kelly R Culwell; Clint Dart; Brandon Howard
Journal:  Contracept X       Date:  2020-07-01

Review 4.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

5.  Vaginal microbicide and diaphragm use for sexually transmitted infection prevention: a randomized acceptability and feasibility study among high-risk women in Madagascar.

Authors:  Frieda M Behets; Abigail Norris Turner; Kathleen Van Damme; Ny Lovaniaina Rabenja; Noro Ravelomanana; Teresa A Swezey; April J Bell; Daniel R Newman; D'Nyce L Williams; Denise J Jamieson
Journal:  Sex Transm Dis       Date:  2008-09       Impact factor: 2.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.